Skip to main content

IDEXX Laboratories Inc

IDXX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000874716

In the last 90 days, IDEXX Laboratories Inc insiders filed 0 open-market purchases and 1 sale; 1,306 institutions reported holding it in 13F filings for Q2 2026, worth $39.1B in total; 3 superinvestors hold it, including Fundsmith and Weitz Investment Management.

Superinvestors holding IDXX, Q2 2026

3 superinvestors report holding IDEXX Laboratories Inc on Form 13F, worth $555.7M in total. Weight is IDEXX Laboratories Inc's share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding IDXX in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
FundsmithTerry Smith3.9%1,019,887$536.9MReduced−30.4%
Weitz Investment ManagementWally Weitz1.3%35,300$18.6MUnchanged
Harris Associates (Oakmark)Bill Nygren<0.1%455$239.5KReduced−5.6%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of IDXX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    3 superinvestors holding at quarter end

    Reduced
    Fundsmith (−30.4%), Harris Associates (Oakmark) (−5.6%)
  2. Q1 2026

    3 superinvestors holding at quarter end

    Added
    Harris Associates (Oakmark) (+5.9%)
    Reduced
    Fundsmith (−21.9%)
  3. Q4 2025

    3 superinvestors holding at quarter end

    Reduced
    Fundsmith (−28.1%), Weitz Investment Management (−37.9%)
  4. Q3 2025

    3 superinvestors holding at quarter end

    New
    Harris Associates (Oakmark)
    Reduced
    Fundsmith (−1.1%), Weitz Investment Management (−5.8%)
  5. Q2 2025

    2 superinvestors holding at quarter end

    Reduced
    Fundsmith (−0.3%)
  6. Q1 2025

    2 superinvestors holding at quarter end

    New
    Weitz Investment Management
    Reduced
    Fundsmith (−0.5%)
  7. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (0.0%)
  8. Q3 2024

    1 superinvestor holding at quarter end

    Added
    Fundsmith (0.0%)
  9. Q2 2024

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (−1.9%)
  10. Q1 2024

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (−0.5%)
    Sold out
    Maverick Capital
  11. Q4 2023

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    Fundsmith (−7.9%)
  12. Q3 2023

    1 superinvestor holding at quarter end

    Added
    Fundsmith (+0.1%)
    Sold out
    Maverick Capital
  13. Q2 2023

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Added
    Fundsmith (+0.2%)
  14. Q1 2023

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (−14.2%)
  15. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (−4.9%)
    Sold out
    Maverick Capital
  16. Q3 2022

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Added
    Fundsmith (+0.1%)
  17. Q2 2022

    1 superinvestor holding at quarter end

    Added
    Fundsmith (0.0%)
  18. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (−14.7%)
  19. Q4 2021

    1 superinvestor holding at quarter end

    Added
    Fundsmith (0.0%)
  20. Q3 2021

    1 superinvestor holding at quarter end

    Reduced
    Fundsmith (0.0%)
    Sold out
    Maverick Capital
  21. Q2 2021

    2 superinvestors holding at quarter end

    Added
    Fundsmith (+0.5%), Maverick Capital (+4,470.3%)